Resmed believes its artificial intelligence-powered approach to personalizing the settings of its connected CPAP machines can lead to better sleep for people with obstructive apnea. Now the FDA has ...

As shown in the following overview of ResMed’s global leadership position: Quarterly Performance Highlights ResMed delivered strong financial results for Q4 FY2025, with revenue reaching $1.35 billion ...

For my first rating of ResMed, I'm calling a buy, agreeing with today's consensus from Wall St. and more confident than the quant system, which said hold. Key upside factors are new business ...

The New York Stock Exchange-listed ResMed Inc (NYSE: RMD) share price surged more than 3% overnight on Wall Street, bringing the dual-listed sleep tech company within striking distance of its all-time ...

A low-cost digital learning model that uses 10-minute, screen-recorded tutorials to deliver self-paced education in 22 Indian languages is set to scale further across India. After reaching more than ...

Revenue: $1.35 billion, a 10% increase year-over-year. Gross Margin: 61.4%, an expansion of 230 basis points year-over-year. Free Cash Flow: $1.7 billion for fiscal year 2025. Net Income: Increased by ...

July 31 (Reuters) - Resmed (RMD.N), opens new tab beat Wall Street estimates for fourth-quarter profit on Thursday, driven by strong demand for its devices used to manage sleep apnea. The company ...

ResMed reported Q4 FY2025 revenue of $1.35 billion, representing a 10% increase compared to $1.22 billion in Q4 FY2024. This performance exceeded the previous quarter’s revenue of $1.3 billion ...

Resmed announced that it will release its financial and operational results for the fourth quarter of fiscal year 2025 on July 31, 2025, after the market closes. Following the release, management will ...

In this video, I'll unbox the Apple Watch Series 10 and walk you through the complete setup process. I'll show you how to pair it with your iPhone, attach the watch band, and go over the new features ...